Cannabis and Adolescent IQ
Examining the evidence for cannabis-related IQ loss in teenagers and what the research actually shows.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
The headline 'weed lowers teen IQ by 8 points' is real research, but it's been oversimplified. That 8-point drop applied only to the heaviest, most persistent users—not occasional teens—and later work suggests socioeconomic factors explain much of it. Heavy daily use starting young is still a legitimate concern, but the causal story is messier than the sound bites suggest.
Not Medical Advice
This article is not medical advice. It summarizes published research on adolescent cannabis use and cognition. If you are a teenager, a parent, or a clinician making decisions about cannabis use, talk to a qualified healthcare professional who knows your situation. Nothing here substitutes for that conversation.
Plain-Language Summary
The question 'does teen cannabis lower IQ?' has a more nuanced answer than political or commercial narratives suggest.
The most-cited study is the Dunedin birth cohort (Meier et al., 2012), which followed approximately 1,000 New Zealanders from birth to age 38. People who became heavy, persistent cannabis users starting in adolescence showed an average IQ drop of about 8 points by midlife compared to their own childhood baseline Weak / limited [1]. Those who started using cannabis as adults showed no such decline.
That finding entered headlines as 'weed costs teens 8 IQ points.' The reality is significantly more complex:
- The 8-point drop applied only to the heaviest, most persistent users—not occasional teen users.
- A direct reanalysis by Rogeberg (2013) found that socioeconomic status and family factors accounted for much of the observed decline Weak / limited [2].
- Co-twin studies, which compare one twin who uses cannabis to an identical twin who does not, have generally found no cannabis-specific IQ loss after accounting for shared genetics and family environment Strong evidence [3][4]. This suggests shared family and genetic factors explain much of the association.
- Meta-analyses find small cognitive deficits during active adolescent cannabis use or shortly after, with most deficits resolving after days to weeks of abstinence Weak / limited [5].
The bottom line: there is a real signal, especially for heavy early-onset use, but the true size of any cannabis-specific effect and whether it is causal remain contested.
What Probably Works (Findings With Robust Support)
These findings have replicated across multiple study designs and represent the strongest claims in the adolescent cannabis–cognition literature:
Acute impairment is real and established. Recent cannabis use (within hours to days) reliably impairs verbal learning, working memory, attention, and processing speed Strong evidence [5]. This is not in dispute.
Heavy, daily, early-onset cannabis use is associated with worse cognitive performance. Adolescents and young adults who use cannabis daily or near-daily, especially those who start before age 16, show deficits on attention, learning, and executive function tasks compared to non-users or light users Strong evidence [5][6]. The association is consistent across multiple cohorts.
The adolescent brain is still developing into the mid-20s, particularly the prefrontal cortex and the endocannabinoid system. The brain does not reach full maturity until the mid-20s, and the prefrontal cortex—involved in judgment, impulse control, and future planning—develops last Strong evidence [7]. This is a biological reason to be more cautious about cannabis use in adolescence than in adulthood, independent of the IQ data.
Earlier age of onset correlates with worse cognitive, educational, and mental-health outcomes. Starting cannabis use at 14 is associated with worse long-term outcomes than starting at 18 Strong evidence [6][8].
What Might Work (Plausible But Not Conclusively Settled)
A small, persistent IQ decline in heavy adolescent users. The original Dunedin estimate was 8 points; reanalysis and subsequent twin studies suggest any cannabis-specific persistent decline is smaller, perhaps 2–6 points if it exists as a causal effect Weak / limited [1][2][3]. Whether this persists into full adulthood with sustained abstinence remains unclear.
Executive function deficits that extend weeks beyond acute intoxication. Some studies suggest working memory and attention deficits persist for weeks in heavy users, even after acute intoxication wears off Weak / limited [5]. Meta-analyses are mixed on the magnitude and duration.
A dose–response relationship (more use = worse outcomes). Several cohorts show that heavier users have worse cognitive outcomes, but heavier users differ in many other ways (mental health, family environment, socioeconomic status, impulsivity), making confounding difficult to rule out Weak / limited [6].
Reversibility with extended abstinence. It is plausible that cognitive deficits reverse substantially after prolonged abstinence (months to years), but long-term follow-up studies in early-onset users are limited No data.
What Doesn't Hold Up Well
'Cannabis causes an 8-point IQ drop' as a clean causal statement. The Dunedin number is a real observation, but the interpretation as a cannabis-specific causal effect is disputed. Twin studies, which control for shared genetics and family environment, found no significant IQ loss Disputed [3][4]. The most likely interpretation is that the association is partly confounded by socioeconomic factors, family dysfunction, and shared genetic risk.
Light or experimental teen cannabis use causes measurable lasting IQ loss. The evidence for cognitive harm from light use in adolescence is inconsistent and weak Weak / limited [3][5]. Occasional use is not supported by the data as a major IQ risk.
Structural brain changes (smaller hippocampus, reduced cortical thickness) from adolescent cannabis use. Early neuroimaging studies suggested cannabis use was associated with brain structure differences. Larger, better-controlled studies have largely failed to replicate these findings Disputed [9].
CBD-dominant or 'mild' cannabis is safe for the adolescent brain. There is essentially no long-term cohort data on CBD-dominant cannabis or very low-THC products in adolescents No data. Claims about CBD safety are not supported by controlled research.
What We Don't Know
Long-term effects of modern, high-potency products. Most adolescent cohort studies were conducted on cannabis with average THC concentrations of 5–10%. Modern concentrates and vape cartridges often contain 70–90% THC. Whether these higher-potency products carry larger cognitive risks is plausible but unstudied in long-term cohorts No data.
Whether cognitive deficits fully reverse after sustained abstinence. Follow-up studies of early-onset users who quit long-term are limited. It is unknown whether cognitive deficits resolve completely, partially, or not at all after months or years of abstinence.
Causation versus confounding. Co-twin and emerging Mendelian randomization studies suggest the relationship is partly confounded by shared genetic and family factors, but the exact proportion of confounding is not fully settled Disputed [3][4].
The role of cannabinoids other than THC. Almost all human cohort data concerns THC-dominant use. The effects of CBD, terpenes, and other cannabis components on adolescent cognition are essentially unknown No data.
In utero and postnatal cannabis exposure. Whether maternal cannabis use during pregnancy affects the child's later cognitive development is a separate literature, also unsettled No data.
Comparison With Other Adolescent Exposures
For perspective, the estimated cognitive cost of heavy, persistent adolescent cannabis use sits in a similar or smaller range than the well-replicated cognitive effects of heavy adolescent alcohol use Strong evidence [10]. Alcohol is associated with larger deficits in executive function, processing speed, and visuospatial learning, and these deficits are more likely to persist into adulthood.
Other adolescent exposures with comparable or larger cognitive effects include untreated ADHD, childhood lead exposure, severe sleep deprivation, and heavy tobacco use (though tobacco's cognitive effects are generally smaller than alcohol's).
This comparison is not an argument that adolescent cannabis is harmless—it is an argument that the risk should be sized accurately alongside other modifiable risks. A clinician or parent weighing concern about weekly cannabis use in a 15-year-old should consider it in the context of other exposures and risk factors affecting that particular young person.
Risks and Bottom Line
Real risks supported by the evidence:
Cannabis use disorder (CUD). Approximately 1 in 6 people who start cannabis use as adolescents develop CUD, compared with roughly 1 in 10 overall Strong evidence [7]. Adolescent-onset use carries a higher risk of problematic use than adult-onset use.
Worsened outcomes in individuals at genetic risk for psychosis. Heavy adolescent cannabis use is associated with earlier onset of psychotic disorders in people with underlying genetic or family vulnerability Strong evidence [7][11].
Lower educational attainment. Heavy adolescent cannabis use predicts reduced school completion and lower educational outcomes, though confounding by other risk factors (mental health, family instability, socioeconomic status) remains a concern Weak / limited [6].
Acute harms. Motor vehicle and other accidents related to impairment, acute anxiety and panic attacks, cannabinoid hyperemesis syndrome with chronic high-dose use, and exacerbation of underlying anxiety or mood disorders.
Regarding the specific IQ question: There is a real but modest signal that heavy, early-onset, persistent cannabis use is associated with worse cognitive outcomes in adolescence and young adulthood. The often-cited 8-point IQ decline from the Dunedin study is probably an overestimate of the cannabis-specific causal effect, and confounding by socioeconomic and family factors likely explains much of the association. Light or occasional adolescent cannabis use does not have strong evidence of lasting IQ loss. The adolescent brain is still developing, providing a biological rationale for caution even where the epidemiology is uncertain.
Again: this is not medical advice.
Sources
- Peer-reviewed Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences USA. 2012;109(40):E2657–E2664.
- Peer-reviewed Rogeberg O. Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proceedings of the National Academy of Sciences USA. 2013;110(11):4251–4254.
- Peer-reviewed Jackson NJ, Isen JD, Khoddam R, et al. Impact of adolescent marijuana use on intelligence: results from two longitudinal twin studies. Proceedings of the National Academy of Sciences USA. 2016;113(5):E500–E508.
- Peer-reviewed Lyons MJ, Bar JL, Panizzon MS, et al. Neuropsychological consequences of regular marijuana use: a twin study. Psychological Medicine. 2004;34(7):1239–1250.
- Peer-reviewed Scott JC, Slomiak ST, Jones JD, et al. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):585–595.
- Peer-reviewed Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 2014;1(4):286–293.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Peer-reviewed Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. New England Journal of Medicine. 2014;370(23):2219–2227.
- Peer-reviewed Orr C, Spechler P, Cao Z, et al. Grey matter volume differences associated with extremely low levels of cannabis use in adolescence. Journal of Neuroscience. 2019;39(10):1817–1827.
- Peer-reviewed Squeglia LM, Jacobus J, Tapert SF. The effect of alcohol use on human adolescent brain structures and systems. Handbook of Clinical Neurology. 2014;125:501–510.
- Peer-reviewed Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019;6(5):427–436.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Acne — Lab evidence exists for CBD; human proof remains absent. Strong treatments already work.
- Cannabis and Dementia — Review of cannabis efficacy, safety, and limitations in dementia care.
- CBD and Addiction Research — A critical review of what science shows—and doesn't—about CBD in addiction treatment.
- Risks of Cannabis Use in Adolescents — Evidence summary of cannabis-related harms during critical brain development years.
- THC Dose and Anxiety — Low doses may reduce acute anxiety; higher doses increase it. Evidence is limited, risks a...